Sangamo Therapeutics Inc. (SGMO)
NASDAQ: SGMO
· Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT
Sangamo Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -63.31M | -79.45M | -97.94M | -134.84M | -249.68M | -328.05M | -257.83M | -249.51M | -198.5M | -127.17M | -192.28M | -177.8M | -172.33M | -176.34M | -178.3M | -181.48M | -135.3M | -124.09M |
Depreciation & Amortization | 8.08M | 8.76M | 9.36M | 10.23M | 15.53M | 19.14M | 22.19M | 24.62M | 22.38M | 21.2M | 20.56M | 19.98M | 19.39M | 18.68M | 17.64M | 16.44M | 15.13M | 14.07M |
Stock-Based Compensation | 11.42M | 12.26M | 12.38M | 15.21M | 18.08M | 21.8M | 27.36M | 29.5M | 31.11M | 32.24M | 31.65M | 31.48M | 31.56M | 33.12M | 32.96M | 31.52M | 30.33M | 27.61M |
Other Working Capital | 17.28M | 16.35M | 18.01M | -4.97M | -16.82M | -25.13M | -175.89M | -197.48M | -207.63M | -224.7M | -98M | -85.57M | -94.93M | -90.11M | -90.85M | -87.56M | -5.35M | 199.68M |
Other Non-Cash Items | -558K | 466K | 4.55M | 5.24M | 50.9M | 43.29M | 96.74M | 95.83M | 49.54M | 56.12M | -1.24M | -6.32M | -5.16M | -4.34M | -3.66M | 2.78M | 2.2M | 785K |
Deferred Income Tax | n/a | 15K | n/a | -122K | 42K | 42K | 42K | 182K | n/a | n/a | n/a | n/a | n/a | 5K | 11K | 82K | 40K | 71K |
Change in Working Capital | 8.46M | 13.32M | 4.51M | -10.05M | -8.25M | -14.12M | -164.03M | -182.66M | -192.9M | -213.34M | -82.32M | -86.63M | -98.55M | -94.8M | -101.89M | -54.18M | -4.75M | 201.76M |
Operating Cash Flow | -35.9M | -44.63M | -67.14M | -114.33M | -173.38M | -207.21M | -224.84M | -231.35M | -237.68M | -230.95M | -223.63M | -219.29M | -225.09M | -223.68M | -233.25M | -184.83M | -92.34M | 120.22M |
Capital Expenditures | -291K | -267K | -267K | -2.79M | -5.42M | -10.96M | -21.16M | -25.96M | -27.63M | -27.53M | -20.17M | -15.55M | -16.35M | -18.17M | -23.28M | -24.43M | -23.23M | -18.89M |
Cash Acquisitions | n/a | n/a | n/a | n/a | -40.37M | -88.38M | -134.31M | -184.39M | -134.97M | -86.97M | -41.04M | 9.17M | 119K | 65K | n/a | -320K | -586K | -769K |
Purchase of Investments | n/a | n/a | n/a | n/a | -7.44M | -23.33M | -59.55M | -111.32M | -199.57M | -247.86M | -277.39M | -263.39M | -288.04M | -305.98M | -338.16M | -536.16M | -707.25M | -625.13M |
Sales Maturities Of Investments | n/a | n/a | 35.84M | 76.22M | 124.03M | 187.92M | 234.24M | 295.71M | 334.55M | 368.7M | 356.85M | 348.25M | 448.13M | 528.82M | 609.75M | 626.02M | 492.7M | 394.73M |
Other Investing Acitivies | 1.82M | 1.95M | 1.95M | 475K | 40.5M | 88.38M | 134.31M | 184.39M | 134.97M | 120.84M | 79.46M | 29.25M | 104.48M | 70.55M | 65.94M | -60.18M | -364.59M | -364.77M |
Investing Cash Flow | 1.53M | 1.68M | 37.52M | 73.91M | 111.3M | 153.64M | 153.53M | 158.44M | 107.35M | 93.31M | 59.28M | 69.31M | 143.75M | 204.62M | 248.2M | 65.11M | -238.37M | -250.06M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.64M | 1.73M | 1.73M | 1.73M | 3.37M | -192K | -310K | -310K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.93M | -2.44M | -614K | 348K | 450K | 908K | 201K | -171K | -1.29M | -866K | -1.32M | 274K | 2.11M | 4.61M | 5.76M | 10.57M | 11.57M | 9.75M |
Financial Cash Flow | 43.54M | 14.39M | 28.38M | 21.55M | 21.66M | 28.71M | 14.59M | 33.96M | 77.87M | 94.23M | 84.66M | 67.24M | 28.91M | 16.06M | 32.86M | 37.66M | 33.79M | 167.93M |
Net Cash Flow | 12.06M | -28.65M | -3.29M | -17.31M | -40.54M | -24.41M | -55.24M | -38.06M | -50.88M | -42.02M | -78.43M | -82.38M | -52.17M | -2.72M | 47.54M | -82.44M | -297.56M | 37.23M |
Free Cash Flow | -36.19M | -44.89M | -67.41M | -117.11M | -178.79M | -218.16M | -246M | -257.31M | -265.31M | -258.48M | -243.8M | -234.85M | -241.44M | -241.84M | -256.53M | -209.26M | -115.58M | 101.33M |